Belbuca Revenue 'Immaterial,' Says JMP On Rx's Return To BioDelivery From Endo International
December 09, 2016 at 10:36 AM EST
JMP Securities reiterated its Market Outperform rating and $34 price target on Endo International plc - Ordinary Shares (NASDAQ: ENDP), ...